• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Renaissance Rx

Anonymous

Guest
Mr. Clayton White
Director - Corporate Development


Renaissance RX
1441 Canal Street, >> Suite, >> 421
New Orleans , Louisiana 70112
United States
Company Description: Renaissance RX is a personalized medicine company. At Renaissance Rx we're changing the way physicians manage medications and track drug adherence. The result…... more